Vertex Pharmaceuticals (VRTX) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 4.69% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -16.07% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.88% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 21.66% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 36.53% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.07% |
| Dec 31, 2025 | -21.48% |
| Sep 30, 2025 | -18.64% |
| Jun 30, 2025 | -17.02% |
| Mar 31, 2025 | -14.96% |
| Dec 31, 2024 | -12.39% |
| Sep 30, 2024 | -5.84% |
| Jun 30, 2024 | -8.93% |
| Mar 31, 2024 | 13.25% |
| Dec 31, 2023 | 20.08% |
| Sep 30, 2023 | 27.52% |
| Jun 30, 2023 | 28.08% |
| Mar 31, 2023 | 37.25% |
| Dec 31, 2022 | 50.05% |
| Sep 30, 2022 | 39.23% |
| Jun 30, 2022 | 38.23% |
| Mar 31, 2022 | 37.97% |
| Dec 31, 2021 | 36.87% |
| Sep 30, 2021 | 36.30% |
| Jun 30, 2021 | 41.39% |
| Mar 31, 2021 | 46.72% |
| Dec 31, 2020 | 53.20% |
| Sep 30, 2020 | 56.98% |
| Jun 30, 2020 | 58.08% |
| Mar 31, 2020 | 332.02% |
| Dec 31, 2019 | 37.97% |
| Sep 30, 2019 | 67.76% |
| Jun 30, 2019 | 75.85% |
| Mar 31, 2019 | 68.56% |
| Dec 31, 2018 | 54.77% |
| Sep 30, 2018 | 48.54% |
| Jun 30, 2018 | 35.07% |
| Mar 31, 2018 | 44.26% |
| Dec 31, 2017 | 38.62% |
| Sep 30, 2017 | 24.45% |
| Jun 30, 2017 | 42.74% |
| Mar 31, 2017 | -52.81% |
| Dec 31, 2016 | 27.64% |
| Sep 30, 2016 | 7.26% |
| Jun 30, 2016 | 4.48% |